NCT02756598View on ClinicalTrials.gov

Stress, Anxiety and Type A Personality and Analgesics

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 1, 2018

Study Completion Date

June 30, 2018

Conditions
Postoperative; Dysfunction Following Cardiac Surgery
Interventions
DRUG

Sufentanil I

bolus dose of sufentanil 1 microgram/kg

DRUG

Sufentanil II

bolus dose of sufentanil 0.5 microgram/kg

DRUG

Propofol I

Continued dose of propofol 0.03 mg/kg/min

DRUG

Propofol II

Continued dose of propofol 0.06 mg/kg/min

All Listed Sponsors
lead

Aarhus University Hospital

OTHER

NCT02756598 - Stress, Anxiety and Type A Personality and Analgesics | Biotech Hunter | Biotech Hunter